# SUGAMMADEX
> **ANDA214230** · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2025-12-01
## Drug
- **FDA Application Number:** ANDA214230
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUGAMMADEX
- **Generic name:** Sugammadex
- **Active ingredients:** SUGAMMADEX
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MANKIND PHARMA
- **First approval:** 2025-12-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214230)
---
*MORVS · CC0 1.0*